After years of disappointments, the C. difficile vaccine field is quietly repositioning itself. While GSK has officially dropped its own toxoid candidate from the pipeline, at least two other toxin‑based approaches—one...
Brazil develops and rolls out single-dose dengue vaccine This article signals a major advance toward operationally feasible dengue vaccination, especially in high-burden, access constrained settings, and may preview...
Download Infographic Overview Classical vaccine manufacturing is a structured 5-step process that transforms a biological seed into a safe, injectable vaccine. It begins with antigen production, where microbes or cells...
Broad Immunity from Naturally Occurring Influenza Antibodies The findings indicate that broadly neutralizing human antibodies can target conserved epitopes in the HA head, not just the stem, broadening the conceptual...
EMA backs first mRNA flu–COVID combination vaccine for older adults The EMA’s CHMP has issued a positive opinion for Moderna’s mRNA combination vaccine “mCombriax,” targeting both seasonal influenza and COVID‑19 in...
Artificial intelligence is rapidly reshaping the life sciences industry. From protein structure prediction to automated clinical documentation, AI systems are beginning to influence nearly every stage of biomedical...
The trajectory of vaccine development in high‑income countries is approaching a turning point. With the licensure of respiratory syncytial virus (RSV) vaccines and monoclonal antibodies, most high‑incidence, high‑burden...
Download Infographic Overview An adverse event (AE) is any medical event occurring after vaccination, regardless of whether it is causally related. A side effect is a medical event that is confirmed to be caused by a...
The Lancet has spoken when a leading medical journal titles an editorial “Robert F Kennedy Jr: 1 year of failure,” the experiment in anti‑expert governance is clearly not going well. RFK Jr arrived at HHS promising...